X0202 SCHEDULE 13G/A 0000902664-22-004027 0001943105 XXXXXXXX LIVE 2 Class A Ordinary Shares, par value $0.0015 per share 03/31/2026 0001876431 Prenetics Global Ltd G72245122 7/F, K11 ATELIER, 728 KING'S ROAD QUARRY BAY K3 000000 Rule 13d-1(c) Genetel Bioventures Ltd K3 488857.00 0.00 488857.00 0.00 488857.00 N 3.3 OO Michael Yang Mengsu F4 488857.00 0.00 488857.00 0.00 488857.00 N 3.3 IN Prenetics Global Ltd Unit 703-706, K11 Atelier King's Road 728 King's Road, Quarry Bay, Hong Kong. This statement is filed by: (i) Genetel Bioventures Limited ("Genetel"), a Hong Kong private limited company; and (ii) Michael Yang Mengsu ("Mr. Yang Mengsu"), the controlling shareholder of Genetel. The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons." The filing of this statement should not be construed as an admission that any of the foregoing persons or any Reporting Person is, for the purposes of Section 13 of the Securities Exchange Act of 1934, the beneficial owner of the securities reported herein. The address of the business office of each of the Reporting Persons is 7B Yardley Commercial Building, 3 Connaught Road West, Sheung Wan, Hong Kong. Genetel is a Hong Kong private limited company. Mr. Yang Mengsu is a citizen of China (Hong Kong SAR). Y The information required by Item 4(a) is set forth in Row 9 of the cover page for each of the Reporting Persons and is incorporated herein by reference. The percentage set forth in this Schedule 13G is calculated based upon an aggregate of 14,697,463 Class A Ordinary Shares outstanding as of March 31, 2026, as reported in the Company's Registration Statement on Form F-3 filed with the Securities and Exchange Commission on March 31, 2026. 3.3% The information required by Item 4(c)(i) is set forth in Row 5 of the cover page for each of the Reporting Persons and is incorporated herein by reference. The information required by Item 4(c)(ii) is set forth in Row 6 of the cover page for each of the Reporting Persons and is incorporated herein by reference. The information required by Item 4(c)(iii) is set forth in Row 7 of the cover page for each of the Reporting Persons and is incorporated herein by reference. The information required by Item 4(c)(iv) is set forth in Row 8 of the cover page for each of the Reporting Persons and is incorporated herein by reference. N Y N See Item 2(a). Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Genetel Bioventures Ltd /s/ George William Hunter Cautherley 04/22/2025 Michael Yang Mengsu /s/ Michael Yang Mengsu 04/22/2025